A Borg

发表

Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies

J. Kere, L. Aaltonen, P. Møller, 2006, Journal of Medical Genetics.

Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

P. Møller, Å. Borg, N. Loman, 2001, Human molecular genetics.

DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

J. Herman, S. Baylin, B. Ponder, 2001, Human molecular genetics.

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes

A Borg, N Loman, H Olsson, 1998, Cancer.

Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation

J C Murray, R Pfundt, R. Pfundt, 2007, Journal of Medical Genetics.

Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.

J Isola, Å. Borg, O. Kallioniemi, 1997, Cancer research.

Tumour biological features of BRCA1-induced breast and ovarian cancer.

Å. Borg, O. Johannsson, H. Olsson, 1997, European journal of cancer.

MYB oncogene amplification in hereditary BRCA1 breast cancer.

J M Trent, J Isola, J. Trent, 2000, Cancer research.

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

H A Risch, J. Hopper, M. Southey, 2008, British Journal of Cancer.

A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.

S. Hilsenbeck, W. Friedrichs, P. O’Connell, 2000, Cancer research.

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Kerstin, Å. Borg, O. Johannsson, 2000, Journal of the National Cancer Institute.

Indicators of prognosis in node-negative breast cancer.

M. Fernö, Å. Borg, H. Olsson, 1990, The New England journal of medicine.